# Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-telitacicept-in-primary-sjogren-s-syndrome-a-randomized/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dong Xu,Jianmin Fang,Shangzhu Zhang,Cibo Huang,Chenghui Huang,Qin Li,Xiaomei Li,Meiqing Chen,Xiumei Liu,Yi Liu,Zhijun Li,Jiankang Hu,Chunde Bao,Wei Wei,Jing Tian,Xinwang Duan,Xiaofeng Zeng |
| Citations | 75 |
| DOI | 10.1093/rheumatology/kead265 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4383058261 |
| PMID | 37399108 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Xinwang Duan](https://scholariq.org/researchers/xinwang-duan/)

## Paper journal

- [Lara D. Veeken](https://scholariq.org/journals/lara-d-veeken/)

## Paper primary topic

- [Salivary Gland Disorders and Functions](https://scholariq.org/topics/salivary-gland-disorders-and-functions/)

## Paper topics

- [Salivary Gland Disorders and Functions](https://scholariq.org/topics/salivary-gland-disorders-and-functions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.